Business Wire

Bluehole Publishes an Industry Comment on the First FDA-authorized Closed Pod Vape Equipped with FEELM Tech.

Share

China’s leading vaping media, Bluehole New Consumption, today publishes an industry comment on the first FDA-authorized closed pod vape equipped with FEELM Tech.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220427006228/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

(Photo: Business Wire)

Here below is the full article:

The FDA (the Food and Drug Administration) has issued marketing granted orders to NJOY Ace and its tobacco-flavored e-liquid pods on April 26. It is the first e-cigarette authorized by the FDA that is equipped with ceramic coils and manufactured by FEELM, the flagship atomization tech brand belonging to SMOORE.

NJOY has partnered with SMOORE since 2009. NJOY Ace was launched in 2018 and is powered by FEELM inside, the world’s first black ceramic atomization coil with metallic film. As the first ceramic coil e-cigarette and pod vape authorized by the FDA, NJOY Ace's approval for sale fully showcases the harm reduction potential of FEELM ceramic coil. According to the FDA, NJOY Ace is authorized for sale because "chemical testing was sufficient to determine that overall harmful and potentially harmful constituent (HPHC) levels in the aerosol of these products is lower than in combusted cigarette smoke."

Based on PMTA requirements, SMOORE has established a comprehensive analytical testing and safety assessment system, including the vaping industry's first corporate toxicology laboratory, which explores the health impacts of exposure to e-cigarette vapor by means of cytotoxicity test, evaluating the reaction of living cells to different components of e-cigarette vapor. The company has also developed the third generation of in-house safety standards SMOORE 3.0, which covers all of the PMTA tests and HPHCs (Harmful and Potentially Harmful Constituents) listed by the FDA.

“The principle of PMTA is to scientifically and systematically substantiate harm reduction performance of the vaping product and show it is appropriate for the protection of the public health (APPH)”, said Dr. Long, Director of SMOORE Analytical Testing and Safety Assessment Center. "The manufacturer must demonstrate the product's potential to switch adult smokers while preventing youth and non-smokers from nicotine addiction," which could explain that all the FDA-authorized vaping products are tobacco-flavored, and popular flavored products have been issued Marketing Denial Orders. It also indicates that vaping manufacturers shall focus on tobacco flavor reproduction and improve harm reduction performance, in order to be approved under the PMTA pathway.

According to Nielsen, for the two weeks ended April 9, 2022, Vuse has surpassed Juul and become the No.1 in the U.S e-cigarette sales, with a market share of 35%. Its flagship product Vuse Alto is also equipped with FEELM ceramic coils. As the No.3 player in the U.S, NJOY accounts for approximately 3.1% market share. Moreover, a federal judge has required the FDA to provide progress reports on PMTAs submitted by major vaping brands. It is expected that more major vaping brands, such as Vuse and Juul, will receive their FDA status reports soon.

To read the original article, please visit: https://www.bluehole.com.cn/news/detail/49641

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Chen Bianji
(86)13530848319

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Unity Game Developers Can Now Enable Direct-to-Consumer Monetization With Xsolla’s New SDK12.8.2025 16:00:00 EEST | Press release

Xsolla, a global commerce company helping developers launch, grow, and monetize their games, today announces the launch of an SDK for Unity that expands monetization capabilities for developers using the Unity engine. This new SDK is a part of Xsolla’s continued mission to unlock direct-to-consumer revenue opportunities across all platforms - mobile, PC, and the web - without complex backend work. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250812923531/en/ (Graphic: Xsolla) Whether building a mobile-first title, a PC game, or a browser-based game, Unity developers can now integrate payments, enable in-game purchases, and create custom storefronts without relying on closed platforms. With a fast time-to-market, developers can start selling directly to their players and retain more of their revenue from day one, while maintaining full ownership of the checkout experience, player data, and monetization strategy. Key benefit

Gogo Galileo HDX Connectivity Option Now Available on Cessna Citation CJ4 Gen312.8.2025 16:00:00 EEST | Press release

Customers who will be taking delivery of the Cessna Citation CJ4 Gen3 business jet now have the option to include the Gogo Galileo HDX connectivity solution installed on their aircraft. By integrating Gogo Galileo HDX, customers can benefit from an additional global connectivity solution that delivers exceptional performance. Announced in October 2024, the CJ4 Gen3 is expected to enter into service in 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250812553974/en/ Gogo Galileo HDX connectivity option now available on Cessna Citation CJ4 Gen3 (Photo Credit: Textron Aviation). The Cessna Citation CJ4 Gen3 is designed and manufactured by Textron Aviation Inc., a Textron Inc. (NYSE:TXT) company. “Cessna Citation business jets are known for their luxury and productivity,” said Lannie O’Bannion, senior vice president, Sales & Marketing. “Whether for work or entertainment, this robust solution ensures customers’ in-flight exp

Pacific Avenue Capital Partners, a Leading Middle Market Private Equity Firm, Announces the Closing of More Than $1.65 Billion in Committed Capital12.8.2025 15:30:00 EEST | Press release

Pacific Avenue Capital Partners (“Pacific Avenue”), a leading global private equity firm focused on corporate carve-outs and other complex situations in the middle market, today announced the closing of its second fund, Pacific Avenue Fund II, with more than $1.65 billion in committed capital. This includes a €100+ million sidecar vehicle that will be used alongside Fund II to pursue European opportunities. Fund II and the European sidecar were each raised in a single closing and completed in less than four months. The vehicles were significantly oversubscribed and received strong support from both new and existing investors. “We are incredibly grateful for the strong support and confidence shown by our existing and new investors,” said Chris Sznewajs, Founder and Managing Partner of Pacific Avenue. “The overwhelmingly strong demand for Fund II and the European sidecar is a clear validation of our strategy.” Pacific Avenue strives to be the premier global partner for corporate carve-ou

LevelBlue and Akamai Partner to Launch New Managed Web Application and API Protection Services12.8.2025 15:00:00 EEST | Press release

LevelBlue, a leading provider of managed security services, strategic consulting, and threat intelligence, today announced the launch of its Managed Web Application and API Protection (WAAP) security service, designed to deliver adaptive, always-on protection that can reduce risk and operational overhead for web application and API security. Powered by Akamai’s industry-leading App & API Protector technology, LevelBlue Managed WAAP combines next-gen web application firewall (WAF), distributed-denial-of service (DDoS) mitigation, bot protection, and foundational API security capabilities paired with LevelBlue’s dedicated WAAP Operations team. Organizations globally are rapidly scaling their use of applications and APIs to power digital-first strategies. According to Enterprise Strategy Group, the average number of web applications per organization is expected to grow from 145 to more than 200 within two years. Simultaneously, the number of organizations with more than half of their appl

Agendia Announces Publication in JNCI Cancer Spectrum Demonstrating that MammaPrint ® Predicts Chemotherapy Benefit in HR+HER2- Early Breast Cancer Using Real-World Evidence from the FLEX Study12.8.2025 15:00:00 EEST | Press release

Agendia, Inc., a leader in innovative genomic testing for breast cancer, today announced the publication of new findings in JNCI Cancer Spectrum validating the predictive utility of the MammaPrint 70-gene assay for chemotherapy benefit in patients with hormone receptor-positive, HER2-negative (HR+HER2-) early-stage breast cancer. The peer-reviewed article, titled "MammaPrint Predicts Chemotherapy Benefit in HR+HER2- Early Breast Cancer: FLEX Registry Real-World Data," highlights how the MammaPrint Index predicts benefit from chemotherapy using a real-world, prospective, observational dataset. The findings are based on data from the ongoing FLEX Study (NCT03053193), a real-world data (RWD) study designed to collect whole transcriptome genomic data annotated with clinical data and outcomes from patients undergoing standard of care MammaPrint testing. This analysis included a propensity-score matched cohort of 1,002 patients with HR+HER2- breast cancer who received either chemotherapy wit

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye